- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00290199
Foley Catheter for Labor Induction in Women With Term and Near Term Membrane Rupture
April 12, 2017 updated by: Alan Tita, University of Alabama at Birmingham
A Randomized Controlled Trial of Foley Catheter for Labor Induction in Women With Term and Near Term Prelabor Rupture of Membranes (PROM)
In women undergoing labor induction for membrane rupture at or near term, we are investigating the addition of a foley catheter placed in the cervix to standard therapy (oxytocin administration) to decrease the time from the start of the induction to delivery.
Study Overview
Status
Terminated
Intervention / Treatment
Detailed Description
To compare the efficacy of a transcervical Foley catheter with concurrent oxytocin administration compared to oxytocin infusion alone for cervical ripening and labor induction in women with premature rupture of membranes (PROM) at > 34 weeks.
Study Type
Interventional
Enrollment (Actual)
169
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35249
- University of Alabama at Birmingham
-
-
Delaware
-
Newark, Delaware, United States, 19713
- Christiana Care Health System
-
-
South Carolina
-
Greenville, South Carolina, United States, 29605
- Greenville Hospital System University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 55 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Preterm rupture of membranes (PROM) (Rupture of membranes = pooling/ferning/nitrazine +) Rupture of membranes (ROM) for ≥1 hour prior to starting induction
- Cervix ≤ 2 centimeters (cm)
- Gestational age ≥ 34 weeks by best obstetric estimate and clinical management decision is delivery
- Singleton gestation
- Cephalic
- Vertex well applied to cervix
Exclusion Criteria:
- Regular uterine contractions (contractions more frequent than every 5 minutes)
- Two prior transverse uterine incisions/vertical uterine incision/ transmural myomectomy or any obstetric contraindication to labor
- Evidence of chorioamnionitis (temperature of 100.4°F with uterine tenderness and maternal or fetal tachycardia or purulent discharge)
- Lethal fetal anomalies
- Intrauterine fetal demise (IUFD)
- Previa
- Suspected abruption/significant hemorrhage
- Non-reassuring fetal heart rate (FHR) pattern
- Non vertex fetal presentation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Transcervical Foley Catheter
|
Foley catheter placed through cervix for cervical ripening
|
No Intervention: No Foley
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hours From Placement of Foley or Initiation of Oxytocin to Delivery
Time Frame: Time from induction to delivery
|
The outcome measure is the mean in hours of the time from induction to delivery (up to 24 hours)
|
Time from induction to delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of Delivery (Vaginal or Cesarean)by 24 Hours
Time Frame: from start of induction to 24 hours post start of induction
|
The percent of subjects having transcervical foley catheter and percent of subjects not having transcervical foley catheter delivering within 24 hours.
|
from start of induction to 24 hours post start of induction
|
Cesarean Rate
Time Frame: at delivery
|
The percent of subjects enrolled who had a cesarean at any time for any reason for delivery.
|
at delivery
|
Induction to Vaginal Delivery Interval
Time Frame: time from induction to vaginal delivery, up to 24 hours
|
Mean hours from time of induction to vaginal delivery interval.
|
time from induction to vaginal delivery, up to 24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Alan T Tita, MD, University of Alabama at Birmingham
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2005
Primary Completion (Actual)
May 1, 2008
Study Completion (Actual)
May 1, 2008
Study Registration Dates
First Submitted
February 9, 2006
First Submitted That Met QC Criteria
February 9, 2006
First Posted (Estimate)
February 10, 2006
Study Record Updates
Last Update Posted (Actual)
May 23, 2017
Last Update Submitted That Met QC Criteria
April 12, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- F051021005
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fetal Membranes, Premature Rupture
-
Shaare Zedek Medical CenterUnknownPremature Rupture of Fetal Membranes
-
University Hospital, Clermont-FerrandBiosynex CompanyRecruitingPremature Rupture of MembraneFrance
-
Ain Shams UniversityUnknownRupture of Membranes; PrematureEgypt
-
Common SenseUnknown
-
Regional Obstetrical ConsultantsTerminatedPreterm Premature Rupture of MembranesUnited States
-
Ain Shams Maternity HospitalAin Shams UniversityUnknownPreterm Premature Rupture of MembranesEgypt
-
Cook Group IncorporatedCompleted
-
Hillel Yaffe Medical CenterUnknownPremature Rupture of Fetal MembranesIsrael
-
Nilratan Sircar Medical CollegeCompletedPremature Rupture of Membranes at TermIndia
-
Ain Shams Maternity HospitalUnknownPreterm Premature Rupture of Membranes
Clinical Trials on Transcervical Foley catheter
-
University of Alabama at BirminghamCompletedCervical Ripening | Labor InductionUnited States
-
Icahn School of Medicine at Mount SinaiWithdrawn
-
Christiana Care Health ServicesThomas Jefferson UniversityCompletedLabor; Forced or Induced, Affecting Fetus or NewbornUnited States
-
Seoul National University HospitalCompletedFailed Induction of LaborKorea, Republic of
-
University of Alabama at BirminghamCompletedPregnancy RelatedUnited States
-
University of California, San FranciscoTerminatedLabor, Induced | Cervical RipeningUnited States
-
Seoul National University HospitalCompletedFailed Induction of LaborKorea, Republic of
-
Northwestern UniversityTerminated
-
The University of Texas Medical Branch, GalvestonCompleted
-
The University of Texas Medical Branch, GalvestonActive, not recruitingLabor Induction | Early AmniotomyUnited States